Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Crawley

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The British Journal of Addiction to Alcohol and Other Drugs|November 1, 1971
A case-note study of 134 out-patient drug addicts over a 17-month periodJ A Crawley
Gut|January 23, 1999
Cost effectiveness of treatment for gastro-oesophageal reflux diseaseJ A Crawley
JAMA|April 10, 1981
Cimetidine postmarket outpatient surveillance programJ A Crawley, J S Gardner, J G Lee
Alimentary Pharmacology & Therapeutics|May 12, 2010
Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbancesD Johnson, J A Crawley, C Hwang, et al.
The American Journal of Managed Care|May 26, 1999
Determining the cost of gastroesophageal reflux disease: a decision analytic modelS S Holzer, T R Juday, B Joelsson, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
The burden of illness of gastro-oesophageal reflux disease: impact on work productivityB B Dean, J A Crawley, C M Schmitt, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux diseaseD A Revicki, J A Crawley, M W Zodet, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The British Journal of Addiction to Alcohol and Other Drugs|November 1, 1971
A case-note study of 134 out-patient drug addicts over a 17-month periodJ A Crawley
Gut|January 23, 1999
Cost effectiveness of treatment for gastro-oesophageal reflux diseaseJ A Crawley
JAMA|April 10, 1981
Cimetidine postmarket outpatient surveillance programJ A Crawley, J S Gardner, J G Lee
Alimentary Pharmacology & Therapeutics|May 12, 2010
Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbancesD Johnson, J A Crawley, C Hwang, et al.
The American Journal of Managed Care|May 26, 1999
Determining the cost of gastroesophageal reflux disease: a decision analytic modelS S Holzer, T R Juday, B Joelsson, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
The burden of illness of gastro-oesophageal reflux disease: impact on work productivityB B Dean, J A Crawley, C M Schmitt, et al.
Alimentary Pharmacology & Therapeutics|December 14, 1999
Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux diseaseD A Revicki, J A Crawley, M W Zodet, et al.
Pageof 1